Jamie heywood biography
- James Heywood is an American MIT mechanical engineer who founded with his family the ALS Therapy Development Institute (ALS TDI) when his younger brother.
- James Heywood is an American MIT mechanical engineer who founded with his family the ALS Therapy Development Institute when his younger brother Stephen Heywood was diagnosed with amyotrophic lateral sclerosis in December 1998.
- Jamie Heywood, an Massachusetts Institute of Technology-trained mechanical engineer, entered the field of translational medicine when his 29-year-old.
- •
Jamie Heywood
American MIT mechanical engineer (born 1966)
James Heywood (born October 4, 1966, in London, England) is an American MITmechanical engineer who founded with his family the ALS Therapy Development Institute (ALS TDI) when his younger brother Stephen Heywood was diagnosed with amyotrophic lateral sclerosis (ALS) in December 1998. He is currently a director at AOBiome, as well as founder and CEO of PatientsLikeMe.[1]
ALS Therapy Development Institute
Main article: ALS Therapy Development Institute
Conceived while James Heywood was moving cross country in March 1999 to be with his family, ALS TDI became the world's first non-profit biotechnology company and pioneered a new model for accelerating translational research by directly hiring scientists to develop treatments outside of the academic and for-profit corporate architecture.[2] The institute's initial approach focused on gene therapy and stem cells and ALS TDI was the first to publish on the safety of the use of stem cells in ALS patients.[3] ALS TDI then pioneered a n
- •
Jamie Heywood
An MIT engineer, Jamie entered the field of translational research and medicine when his brother Stephen was diagnosed with ALS in 1998 at the age of 29. With experience in design, information technology, systems modeling, neuroscience and industrial engineering, Jamie brings a unique perspective to drug discovery and medicine. The scientific and business innovations he developed at ALS TDI and PatientsLikeMe have been transforming the intersection of biotechnology and pharmaceutical development, personalized medicine, and patient care. Formerly, Jamie served as chairman of PatientsLikeMe, where he provided the scientific vision and architecture for its patient-centered medical platform. He co-founded the company in 2005 with his youngest brother, Benjamin, and friend, Jeff Cole. Named one of “15 companies that will change the world” by CNNMoney, PatientsLikeMe is a personalized research and peer care platform that allows patients to share in-depth information on treatments, symptoms and outcomes. This novel open model allows clinicians, providers, and
- •
In conversation with… Jamie Heywood, zolar
[00:00:04.490] – Jon Slowe
Welcome to Talking New Energy, a podcast from LCP Delta. I'm Jon Slowe.
[00:00:09.290] – Sandra Trittin
And I'm Sandra Trittin, and together we are exploring how the energy transition is unfolding across Europe through conversations with guests from the leading edge of the transition.
[00:00:22.850] – Jon Slowe
Hello, and welcome to the episode. So, Sandra, I'm really excited about the conversation we have today because it's someone from outside the energy sector who's come into the energy sector recently. And I'm excited because I think we need these skills and perspectives from other places, like tech, media, telecoms in the energy sector to really drive the transition forward.
[00:00:49.890] – Sandra Trittin
Yes, I think also the energy sector is transforming, right. Especially all the IoT (Internet of Things) communication part plays really an important role. Then also other topics like supply chain management, et cetera. So, yeah, looking forward to our guest today.
[00:01:07.620] – Jon Sl
Copyright ©bandfull.pages.dev 2025